
Trump Administration Moves to Restrict Obamacare Enrollment Period
In a significant policy shift, the Trump administration is preparing to implement new restrictions on the enrollment period for the Affordable Care Act (ACA), commonly known as Obamacare. This measure aims to limit the time frame during which individuals can sign up for health insurance through the government marketplace. Advocates for affordable healthcare have expressed serious concerns about the potential impacts on millions who depend on these services.
Continue reading
HIV Funding Crisis Sparks Worry Over Increased Risk of Airborne Diseases
Amid a concerning lack of support for HIV initiatives, experts are sounding alarms about the potential rise in airborne diseases, linking the deterioration of funding and resources directly to the health risks communities may face. The situation has escalated to a point where experts warn that the focus on HIV has diminished significantly, leaving gaps that could lead to an uptick in other infectious diseases.
Continue reading
FTC Takes Action Against CVS, Cigna, and UnitedHealth Over Allegations of Abuse in Pharmaceutical Middleman Role
In a significant move that could reshape the landscape of the pharmaceutical industry, the Federal Trade Commission (FTC) has launched an investigation into three prominent players—CVS Health, Cigna, and UnitedHealth Group. The agency accuses these companies of exploiting their positions as pharmacy benefit managers (PBMs) and engaging in practices that allegedly harm consumers and distort competition.
Continue reading